Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Taranabant> ?p ?o. }
Showing items 1 to 65 of
65
with 100 items per page.
- Taranabant abstract "Taranabant (codenamed MK-0364) is a cannabinoid receptor type 1 inverse agonist being investigated as a potential treatment for obesity due to its anorectic effects. It was discovered by Merck & Co.In October 2008, Merck has stopped its phase III clinical trials with the drugs due to high level of central side effects, mainly depression and anxiety.".
- Taranabant atcPrefix "A08".
- Taranabant atcSuffix "AX".
- Taranabant casNumber "701977-09-5".
- Taranabant fdaUniiCode "X9U622S114".
- Taranabant iupacName "N-[(2S,3S)-4-(4-chlorophenyl)-3-(3-cyanophenyl)-2-butanyl]-2-methyl-2-{[5-(trifluoromethyl)-2-pyridinyl]oxy}propanamide".
- Taranabant pubchem "11226090".
- Taranabant thumbnail Taranabant.png?width=300.
- Taranabant wikiPageID "16657658".
- Taranabant wikiPageRevisionID "593126655".
- Taranabant atcPrefix "A08".
- Taranabant atcSuffix "AX".
- Taranabant c "27".
- Taranabant casNumber "701977".
- Taranabant cl "1".
- Taranabant f "3".
- Taranabant h "25".
- Taranabant hasPhotoCollection Taranabant.
- Taranabant iupacName "N-[-4--3--2-butanyl]-2-methyl-2-{[5--2-pyridinyl]oxy}propanamide".
- Taranabant molecularWeight "515.95".
- Taranabant n "3".
- Taranabant o "2".
- Taranabant pubchem "11226090".
- Taranabant routesOfAdministration "Oral".
- Taranabant unii "X9U622S114".
- Taranabant verifiedrevid "448081332".
- Taranabant watchedfields "changed".
- Taranabant subject Category:Amides.
- Taranabant subject Category:Anorectics.
- Taranabant subject Category:CB1_receptor_antagonists.
- Taranabant subject Category:Cannabinoids.
- Taranabant subject Category:Nitriles.
- Taranabant subject Category:Organochlorides.
- Taranabant subject Category:Organofluorides.
- Taranabant subject Category:Pyridines.
- Taranabant type Abstraction100002137.
- Taranabant type Amide114724264.
- Taranabant type Amides.
- Taranabant type Base114618253.
- Taranabant type Chemical114806838.
- Taranabant type Compound114818238.
- Taranabant type Material114580897.
- Taranabant type Matter100020827.
- Taranabant type Nitrile114827346.
- Taranabant type Nitriles.
- Taranabant type OrganicCompound114727670.
- Taranabant type Part113809207.
- Taranabant type PhysicalEntity100001930.
- Taranabant type Pyridine114692510.
- Taranabant type Pyridines.
- Taranabant type Relation100031921.
- Taranabant type Substance100019613.
- Taranabant type Drug.
- Taranabant type DrugProduct.
- Taranabant type FunctionalSubstance.
- Taranabant comment "Taranabant (codenamed MK-0364) is a cannabinoid receptor type 1 inverse agonist being investigated as a potential treatment for obesity due to its anorectic effects. It was discovered by Merck & Co.In October 2008, Merck has stopped its phase III clinical trials with the drugs due to high level of central side effects, mainly depression and anxiety.".
- Taranabant label "Taranabant".
- Taranabant sameAs Taranabant.
- Taranabant sameAs m.03yk5kn.
- Taranabant sameAs Q7685387.
- Taranabant sameAs Q7685387.
- Taranabant sameAs Taranabant.
- Taranabant wasDerivedFrom Taranabant?oldid=593126655.
- Taranabant depiction Taranabant.png.
- Taranabant isPrimaryTopicOf Taranabant.
